ZIVAQ
LIVE

Serial Number

50015153

Owner

Zivaq Pharmaceuticals Inc

Attorney

Unsuk O

First Use Date

May 1, 2025

Filing Date

Jul 27, 2026

Add to watchlist:

No watchlists yet
View on USPTO

ZIVAQ Trademark

Serial Number: 50015153

ZIVAQ is a trademark filed by Zivaq Pharmaceuticals Inc on July 27, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Zivaq Pharmaceuticals Inc

15 Cotters Lane
East Brunswick, NJ 08816

Entity Type: 03

Trademark Details

Filing Date

July 27, 2026

Registration Date

Not Registered

First Use Anywhere

May 1, 2025

First Use in Commerce

May 1, 2025

Goods & Services

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of bone fractures; Pharmaceutical preparations for the treatment of hormonal disorders; Pharmaceutical preparations for the treatment of hyperhidrosis; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicines for the treatment of gastrointestinal diseases; Antiallergic medicines; Probiotic supplements; Nutritional supplement for eliminating toxins from the intestinal tract; Dietary supplement for eliminating toxins from the intestinal tract; Vitamin supplements; Calcium supplements

Filing History

APPLICATION FILING RECEIPT MAILED
Jul 27, 2026 MAFR
NEW APPLICATION ENTERED
Jul 27, 2026 NWAP